폐경 후 여성에서 여성호르몬치료의 고감도 C-반응성 단백에 대한 영향

키워드

참고문헌 (20)

1. Hulley S, "Randomized trial of estrogen plus progestin for secondary prevension of coronary heart disease in postmenopausal women", 280(7), pp.605~613 (1998)
2. Herrington DM, "Effects of estrogen replacement on the progression of coronary-artery atherosclerosis", 343(8), pp.522~529 (2000)
3. Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial", 288(3), pp.321~333 (2002)
4. Manson JE, "Estrogen plus progestin and the risk of coronary heart disease", 349(6), pp.523~534 (2003)
5. Lamon-Fava S, "Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women", 91(2), pp.252~254 (2003)
6. 이정규, "비타민 C 섭취와 혈장 고민감도 C-반응성 단백 농도와의 상관성", 25(4), pp.314~321 (2004)
7. Ridker PM, "Hormone replacement therapy and increased plasma concentration of C-reactive portein", 100(7), pp.713~716 (1999)
8. Koh KK, "Effect of hormone replacement therapy on tissue factor activity, C-reactive portein, and the tissue factor pathway inhibitor", 91, pp.371~373 (2003)
9. Ridker PM, "Prospective studies of C-reactive protein as a risk factor for cardiovascular disease", 46, pp.391~395 (1998)
10. Ridker PM, "C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women", 342(12), pp.836~843 (2000)
11. Cushman M, "Effect of postmenopausal hormones on inflammation-sensitive proteins; the Postmenopausal Estrogen", Progestin Interventions (PEPI) Study, 1999, pp.100, 717~722
12. Van Baal WM, "Increased C-reactive protein levels during short-term hormone replacement therapy in healthy postmenopausal women", 81(6), pp.925~928 (1999)
13. Kim JY, "Effects of hormone therapy on serum hs-CRP levels in surgically menopaused women", 48(7), pp.1752~1759 (2005)
14. Pradhan AD, "Inflammatory biomarker, hormone replacement therapy, and incident coronary heart disease; Prospective analysis from the women's health initiative observational study", 288(8), pp.980~987 (2002)
15. Davison S, "New markers for cardiovascular disease risk in women: Impact of endogenous estrogen status and exogenous postmenopausal hormone therapy", 88(6), pp.2470~2478 (2003)
16. Skouby SO, "Hormeone replacement therapy; estrogen and progestin effects on plasma C-reactive protein concentrations", 186(5), pp.969~977 (2002)
17. Satter N, "Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes", 354(9177), pp.487~488 (1999)
18. Modena MG, "Effects of hormone replacement theraphy on C-reactive protein levels in healthy postmenopausal women: Comparison between oral and transdermal administration of estrogen", 113(4), pp.331~334 (2002)
19. Strandberg TE, "Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women", 92(2), pp.211~214 (2003)
20. Strandberg TE, "Differing effects of oral and transdermal hormone replacement therapy on cardiovascular risk factors in healthy postmenopausal women", 92(2), pp.211~214 (2003)

관련 논문AI추천